AEP Third Quarter 2025 Earnings Presentation October 29, 2025 AEP CONFIDENTIAL Cautionary Note Regarding Forward- Looking Statements This presentation contains forward-looking statements. Words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue" and similar expressions, including statements reflecting future results or guidance and statements of outlook are intended to identify forward-looking statements but are not the exclusive means of id ...

Third Quarter 2025 Earnings October 29, 2025 Click Here to Edit Title Cautionary Statement Click Here to Edit Title This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company's fourth quarter 2025 and full year 2025 outlook including expected sales, expected organic sales, expected earnings per share, expected adjusted earnings per share, expected revenue, esti ...

October 2025 DFINsolutions.com © 2025 DFIN. All rights reserved Investor Presentation This presentation is the intellectual property of DFIN. The ideas expressed in it may not be adopted or reproduced without prior permission from and compensation to DFIN. Forward Looking Statements and Use of Non-GAAP Financial Measures USE OF FORWARD-LOOKING STATEMENTS This presentation includes certain "forward-looking statements" within the meaning of, and subject to the safe harbor created by, Section 21E of the Securi ...

Financial Performance & Strategy - ProPetro reported Q3 2025 revenue of $294 million and Adjusted EBITDA of $35 million[13] - Free Cash Flow for Completions Business in Q3 2025 was $25 million[13] - The company is focused on generating sustainable completions free cash flow through reduced capex and targeted M&A[10] - ProPetro is strategically located in the Permian Basin, with 100% of its completions business revenue derived from this region[20] PROPWR Business - ProPetro is expanding into power generation services with PROPWR, targeting an installed capacity of 1 gigawatt or greater by 2030[12, 34] - PROPWR has secured a letter of intent for a $350 million lease financing facility[31] - Total contracted capacity for PROPWR has expanded to over 150 megawatts, with expectations to reach at least 220 megawatts by year-end[31] - Increased equipment orders to 360 megawatts, with all units expected to be delivered by early 2027 and anticipate 750 megawatts delivered by year-end 2028[33] Fleet Transformation & Capital Allocation - Approximately 70% of ProPetro's active hydraulic horsepower is now secured under long-term contracts[46] - The company has a $200 million share repurchase program, with $89 million remaining as of the report[49, 50]

TSX CG NYSE CGAU STRONG PLATFORM BUILDING A FOR FUTURE GROWTH Third Quarter 2025 Results Conference Call & Webcast OCTOBER 29, 2025 Cautionary Statement on Forward Looking Information All statements, other than statements of historical fact contained or incorporated by reference in this document, which address events, results, outcomes or developments that the Company expects to occur are, or may be deemed to be, forward-looking information or forward-looking statements within the meaning of certain securit ...

Financial Highlights - Core FFO Per Share is $0.48[4] - Cash ABR PSF is $19.61[4] - Quarterly same-property NOI growth is 2.3%[4] - FY 2025 Guidance for Core FFO Per Diluted Share is $1.84 - $1.87[4] Portfolio & Leasing Activity - Leased Occupancy is 94.2%, a 360 bps spread to 90.6% occupancy[4] - Comparable leasing spread is 10%[4] - Approximately 125,000 square feet of comparable leasing activity[4] - SNO Pipeline is $5.5 million, representing 5.3% of in-place ABR[4] - 82% of ABR is from Georgia, Texas, Florida & North Carolina[4, 11] Enterprise Value & Valuation - Enterprise Value is $1.2 billion[5, 11] - Equity Market Cap is $533 million[11] - Net Debt Outstanding is $598 million[11]

Financial Performance - Total revenue reached $800 million, representing a 7% year-over-year increase compared to Q3 2024[30] - Tyvaso DPI and nebulized Tyvaso combined revenue increased by 10% year-over-year to $478 million[30, 58] - Orenitram revenue increased by 16% year-over-year to $131 million[30, 58] - Remodulin revenue decreased slightly by 2% year-over-year to $126 million[30, 58] - Unituxin revenue decreased by 22% year-over-year to $48 million[30, 58] - The company's trailing twelve months (TTM) operating cash flow is $16 billion, and it holds $43 billion in cash, cash equivalents, and marketable investments[31] Pipeline Development - TETON-2 study of nebulized Tyvaso for Idiopathic Pulmonary Fibrosis (IPF) met its primary endpoint[37] - TETON-1 study data for Tyvaso in IPF in the U S and Canada is expected in the first half of 2026[37, 40, 42] - The ADVANCE OUTCOMES study of Ralinepag for Pulmonary Arterial Hypertension (PAH) is fully enrolled with 728 patients, and data is expected in the first half of 2026[47, 50]

Earnings Presentation Third Quarter 2025 Enabling Technology. Growing Sustainably. Legal Notices SAFE HARBOR Please note that in this presentation, we may discuss events or results that have not yet occurred or been realized, commonly referred to as forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of the Company. Such discussion and statements will often contain words such as "expect," "anticipate," "p ...

OCTOBER 29, 2025 Q3 2025 Financial Results Forward-looking Statements 2 This presentation contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include but are not limited to statements relating to: our financial guidance for the fourth quarter of 2025 and underlying assumptions; the impact of AI, ML, and LLMs; the impact of agentic search and our partnership with OpenAI; our product development investments, strategic priorities, and marketing init ...

Q3 2025 Performance Highlights - Organic sales increased by 2%, with Service up by 6%[8] - Adjusted operating profit margin expanded by 20 bps, with Service expanding by 70 bps[8, 16] - Adjusted EPS increased by 9%[8] - Maintenance portfolio units grew by 4%[7, 8] - Modernization orders increased by 27%, and backlog increased by 22% at constant currency[8] - New Equipment orders increased by 4%, at constant currency[8] Orders and Backlog (Q3 2025) - Total Otis orders increased by 9%[9] - New Equipment orders increased by 4%, or 7% excluding China[9] - Modernization orders increased by 27%, or 16% excluding China[9] - Total backlog increased by 3%[9] - New Equipment backlog decreased by 1%, but increased by 8% excluding China[9] - Modernization backlog increased by 22%, or 20% excluding China[9] 2025 Outlook - Net sales are projected to be between $145 billion and $146 billion, with organic growth of approximately 1%[32] - Adjusted operating profit is expected to be between $24 billion and $25 billion, an increase of $75 million to $95 million at actual currency[32] - Adjusted EPS is projected to be between $404 and $408, representing a growth of 5% to 7%[32] - Adjusted free cash flow is estimated to be approximately $145 billion[32]